L-Tyrosine

DIETARY_SUPPLEMENT6 trials

Sponsors

Seton Healthcare Family, Hadassah Medical Organization, John D. Dingell VA Medical Center, New York Institute of Technology, Sheffield Hallam University

Conditions

Blood PressureCognitive ChangeDepressionNemaline MyopathyRestless Legs Syndrome (RLS)Sports Performance

Early Phase 1

The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease

CompletedNCT02259049

New York Institute of TechnologyBlood Pressure

Start: 2014-10-31End: 2015-09-30Updated: 2016-01-20

Phase 2

Treatment of TNNT1-Myopathy With L-Tyrosine.

Hadassah Medical OrganizationNemaline Myopathy

Start: 2014-01-31Target: 10Updated: 2014-01-14

Unknown Phase

Efficacy of Tyrosine in Restless Legs Syndrome

CompletedNCT01494766

Seton Healthcare FamilyRestless Legs Syndrome (RLS)

Start: 2012-01-31End: 2012-11-30Updated: 2017-04-27

Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.

WithdrawnNCT02223299

John D. Dingell VA Medical CenterDepression

Start: 2015-11-30End: 2015-11-30Updated: 2020-02-21

Dopamine Dorsolateral Prefrontal Cortex Behavioural Flexibility

CompletedNCT03068884

Sheffield Hallam UniversityCognitive Change

Start: 2017-03-01End: 2018-01-31Updated: 2018-02-22

Effects of L-Tyrosine and Caffeine on Performance in Elite Boxers

Not yet recruitingNCT07530185

Inonu UniversitySports Performance

Start: 2026-04-01End: 2027-03-01Target: 18Updated: 2026-04-15